Skip to main content

What the FDA labels say about taking them together

Cisatracurium and succinylcholine

Cisatracurium's FDA label of April 4, 2025 names succinylcholine in its drug interactions section; the succinylcholine labels PlainMeds reads (2) do not name cisatracurium. The cisatracurium label: “DRUG INTERACTIONS Succinylcholine: May decrease time to onset of maximum neuromuscular blockade. I nhalational anesthetics, antibiotics, local anesthetics, magnesium salts, procainamide, lithium, quinidine:”

Check it at the source: the cisatracurium FDA label on DailyMed (effective April 4, 2025, Gland Pharma Limited); the succinylcholine FDA label on DailyMed (effective August 18, 2026, Hospira, Inc.).

What does the cisatracurium label say about succinylcholine?

Cisatracurium label, drug interactions

DRUG INTERACTIONS Succinylcholine: May decrease time to onset of maximum neuromuscular blockade. (7.1) I nhalational anesthetics, antibiotics, local anesthetics, magnesium salts, procainamide, lithium, quinidine:

Source: FDA drug label (Cisatracurium besylate), Gland Pharma Limited, effective April 4, 2025 (SPL set 0bacc37a-5e7f-4f05-9206-56fc8041c1ad), via openFDA; the full label on DailyMed

What does the succinylcholine label say about cisatracurium?

Succinylcholine's label (effective August 18, 2026) and its 1 other brand-application label do not name cisatracurium in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (QUELICIN), Hospira, Inc., effective August 18, 2026 (SPL set fb08161e-7711-406d-e7b3-ea4515c07983), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

15Cisatracurium generic labelers
26Succinylcholine generic labelers
CisatracuriumSuccinylcholine
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)n/an/a
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?